Dompé Farmaceutici S.p.a

This study tests an eye drop containing a human nerve growth factor to help heal persistent corneal defects (wounds on the eye's surface that won't close). About 150 adults with such wounds will receive either the active drop or a placebo. The goal is to see if the drop can fully…

This study tests a nasal spray called cenegermin to see if it can improve vision in people who recently lost eyesight from a condition called NAION (a stroke in the optic nerve). About 272 adults will receive either the spray or a placebo. The goal is to measure if more people ga…

This study tests a new eye drop called DFL24498 in people with dry eye disease. About 417 adults will use the drops four times a day for 12 weeks. Researchers will check if the drops improve eye surface health and reduce dryness symptoms compared to a placebo.

This Phase 3 trial tests DFL24498 eye drops in 138 adults with atopic keratoconjunctivitis (AKC), a severe allergic eye condition. The drops are given twice daily for 12 weeks to see if they reduce eye itching and corneal damage compared to a placebo. Participants must have AKC i…